AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 1.87 |
Market Cap | 8.39M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -10.19 |
PE Ratio (ttm) | -0.18 |
Forward PE | n/a |
Analyst | Buy |
Ask | 1.88 |
Volume | 70,711 |
Avg. Volume (20D) | 235,462 |
Open | 1.96 |
Previous Close | 1.91 |
Day's Range | 1.84 - 1.96 |
52-Week Range | 1.70 - 42.92 |
Beta | undefined |
About ICU
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune ...
Analyst Forecast
According to 1 analyst ratings, the average rating for ICU stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.